Showing results (271-280 of 435) with videos related to
Sort By:
Pageof 44
Frontiers in Pharmacology|December 10, 2021
Circular RNA CREBBP Suppresses Hepatic Fibrosis Via Targeting the hsa-miR-1291/LEFTY2 AxisYa-Ru Yang, Shuang Hu, Fang-Tian Bu, et al.Molecular Immunology|August 4, 2020
LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathwayYa-Ru Yang, Fang-Tian Bu, Yang Yang, et al.Plos One|February 25, 2012
Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitroLi-xia Tang, Rui-hua He, Guang Yang, et al.Oncology Reports|January 1, 2016
MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1Qizhuang Li, Quan Cheng, Zigui Chen, et al.International Immunopharmacology|August 12, 2018
Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1Chong Zhang, Xue-Qi Liu, Hao-Nan Sun, et al.Acta Pharmaceutica Sinica. B|July 15, 2026
Discovery of novel tumor-targeting peptide-oncolytic peptide based conjugates (PPCs): A new paradigm for targeted oncolytic-immunotherapyQianyao Yu, Jingfang Yao, Ming Meng, et al.Life Sciences|November 26, 2022
Myc-mediated circular RNA circMcph1/miR-370-3p/Irak2 axis is a progressive regulator in hepatic fibrosisJin-Jin Xu, Xin Chen, Sai Zhu, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 2, 2018
Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCCMing-Fang Li, Yu-Huan Li, Ying-Hua He, et al.Current Protocols in Bioinformatics|March 11, 2015
Using pLink to Analyze Cross-Linked PeptidesSheng-Bo Fan, Jia-Ming Meng, Shan Lu, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 29, 2010
Estrogen stimulates the expression of mismatch repair gene hMLH1 in colonic epithelial cellsPeng Jin, Xiao-juan Lu, Jian-qiu Sheng, et al.Pageof 44